Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Barriers to asthma treatment adherence

Barriers to asthma treatment adherence 430 Pediatric Allergy and Immunology Results: Daily doses of fluticasone were significantly tions in daily treatment to lower doses than can more lowe r in t he eNO group. Alth ou g h exacerbat io ns conventional measures. Although the latter could be used decreased in both groups, there were no significant to guide such decreases, their lack of sensitivity does not differences between the groups for number of exacerba- provide the reassurance that patients and providers seem tions, pulmonary function, use of oral steroids, or to want before reducing treatment below a certain amount. sputum eosinophils. Unfortunately, eNO is substantially more expensive to measure than other parameters, raising the question of whether the reduction in daily treatment dose is worth the Editor’s comments extra cost. Because most patients are substantially nonad- herent to treatment anyway, it is not clear that actual reduc- eNO clearly offers an advantage over less sensitive mea- tion in total treatment in real-world situations will occur sures of airway inflammation in that it can guide reduc- using measurement of eNO. Bender BG, Bender SE: Patient-identified barriers to and cost and a belief that the patient's asthma was not asthma treatment adherence: responses to interviews, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Allergy and Asthma Reports Springer Journals

Barriers to asthma treatment adherence

Current Allergy and Asthma Reports , Volume 5 (6) – May 27, 2005

Barriers to asthma treatment adherence

Abstract

430 Pediatric Allergy and Immunology Results: Daily doses of fluticasone were significantly tions in daily treatment to lower doses than can more lowe r in t he eNO group. Alth ou g h exacerbat io ns conventional measures. Although the latter could be used decreased in both groups, there were no significant to guide such decreases, their lack of sensitivity does not differences between the groups for number of exacerba- provide the reassurance that patients and providers seem tions, pulmonary...
Loading next page...
 
/lp/springer-journals/barriers-to-asthma-treatment-adherence-nkUfH994Pd

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer Journals
Copyright
Copyright © 2005 by Current Science Inc.
Subject
Medicine & Public Health; Allergology; Pneumology/Respiratory System; Otorhinolaryngology; Infectious Diseases
ISSN
1529-7322
eISSN
1534-6315
DOI
10.1007/s11882-005-0021-0
Publisher site
See Article on Publisher Site

Abstract

430 Pediatric Allergy and Immunology Results: Daily doses of fluticasone were significantly tions in daily treatment to lower doses than can more lowe r in t he eNO group. Alth ou g h exacerbat io ns conventional measures. Although the latter could be used decreased in both groups, there were no significant to guide such decreases, their lack of sensitivity does not differences between the groups for number of exacerba- provide the reassurance that patients and providers seem tions, pulmonary function, use of oral steroids, or to want before reducing treatment below a certain amount. sputum eosinophils. Unfortunately, eNO is substantially more expensive to measure than other parameters, raising the question of whether the reduction in daily treatment dose is worth the Editor’s comments extra cost. Because most patients are substantially nonad- herent to treatment anyway, it is not clear that actual reduc- eNO clearly offers an advantage over less sensitive mea- tion in total treatment in real-world situations will occur sures of airway inflammation in that it can guide reduc- using measurement of eNO. Bender BG, Bender SE: Patient-identified barriers to and cost and a belief that the patient's asthma was not asthma treatment adherence: responses to interviews,

Journal

Current Allergy and Asthma ReportsSpringer Journals

Published: May 27, 2005

There are no references for this article.